Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Microbiology & Virology

Virology

A virus is a small infectious agent that replicates inside living cells. Viruses cause many human diseases from small illnesses, like influenza, to more deadly diseases, like hepatitis B and HIV. Our body’s immune system defends against viral infection by generating specific antibodies to bind to and neutralize viral particles and by cell mediated immunity that destroys infected host cells. read more

Items 1-10 of 331

Page
per page
  1. 4-quinolinol
    B7871 4-quinolinol
    Summary: A hydroxylated quinoline derivative
  2. Primaquine Diphosphate
    B1820 Primaquine Diphosphate
    Summary: antimalarial agent,blocks protein synthesis
      insoluble in EtOH; ≥18.85 mg/mL
  3. Artemether (SM-224)
    A4014 Artemether (SM-224)
    Summary: Semi-synthetic derivative of artemisinin
      insoluble in H2O; ≥15.3 mg/mL
  4. Elvitegravir (GS-9137)
    A4070 Elvitegravir (GS-9137)
    Target: HIV Integrases
    Summary: HIV-1 integrase inhibitor,potent
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  5. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     3 Citation
    Target: Thymidylate Synthase
    Summary: Antitumor agent;inhibitor of thymidylate synthase
      insoluble in EtOH; ≥10.04 mg/mL
  6. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
  7. S/GSK1349572
    A4074 S/GSK1349572
    Summary: HIV integrase inhibitor, novel and potent
      ≥41.9 mg/mL
  8. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    Target: HCV Proteases
    Summary: HCV NS3/4A protease inhibitor
      ≥32.6 mg/mL
  9. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL
  10. Telaprevir (VX-950)
    A4031 Telaprevir (VX-950)
    Target: HCV NS3-4A protease
    Summary: HCV NS3-4A protease inhibitor
      ≥32.95 mg/mL

Items 1-10 of 331

Page
per page
Relate Categories
Category
  1. Antibiotic218item
  2. CCR51 item
  3. CMV6item
  4. gp120/CD44item
  5. HBV9item
  6. HCV19item
  7. HIV30item
  8. HSV6item
  9. Influenza A virus6item
  10. NA7item
  11. Reverse Transcriptase11item
  12. RSV2item
  13. SRPK1 item
  14. Antifungal5item
  15. Antimalaria6item
  16. VEEV1 item
Specificity
  1. Selective45item
Target
  1. Peptidylprolyl isomerases1 item
  2. Thymidylate Synthase1 item
  3. Eukaryotic elongation factors1 item
  4. Neuraminidases (NA)2item
  5. Glucan synthase1 item
  6. Reverse Transcriptases6item
  7. CCR1 item
  8. Topoisomerases1 item
  9. Cytochrome P450 (CYP450)3item
  10. Ribosomes1 item
  11. Influenza viruses1 item
  12. Toll-like receptors (TLRs)1 item
  13. HCV Proteases3item
  14. HIV-1 gp1201 item
  15. phosphatases1 item
  16. HIV Integrases1 item
  17. Squalene epoxidases2item
  18. SRPK11 item
  19. HSV1 item
  20. RNA Polymerases2item
  21. HIV-1 reverse transcriptase1 item
  22. Penicillin-binding proteins (PBPs)1 item
  23. Peptidoglycan synthesis1 item
  24. CMV2item
  25. HBV Proteases1 item
  26. IMPDH1 item
  27. Nonstructural protein 5B (NS5B)1 item
  28. Microtubule/Tubulin1 item
  29. Antifungal2item
  30. gp120-CD4 interaction1 item
  31. HCV polymerase2item
  32. ATP synthase1 item
  33. Antibiotic4item
  34. integrase1 item
  35. phosphatidylinositol kinase1 item
  36. Transferases1 item
  37. HCV NS3-4A protease1 item
  38. reverse transcriptase1 item
  39. Substance P/NK1 Receptor1 item
  40. gp120/CD41 item
Reported Experiments
  1. Animal Experiments72item
  2. Cell Experiments60item
Related Disease
  1. Acute Renal Failure1 item
  2. Bacterial Infectios1 item
  3. Bladder Diseases1 item
  4. Breast Cancer1 item
  5. Cancer6item
  6. Cervical Cancer1 item
  7. Colon Cancer1 item
  8. Fungal Infection2item
  9. HCV3item
  10. Hepatitis C4item
  11. HIV11item
  12. HIV Infections7item
  13. Immunosuppressive Therapy1 item
  14. Influenza3item
  15. Leukemia1 item
  16. Melanoma1 item
  17. Multidrug Resistance Studies1 item
  18. Ovarian Cancer1 item
  19. Prostate Cancer1 item
  20. Rheumatoid Arthritis1 item
  21. Sarcoma1 item
  22. Sleep Disorders1 item
  23. Tuberculosis4item